Common Contracts

AMERICAN DEPOSITARY SHARES PURCHASE WARRANT IMMUTEP LIMITED

IMMUTEP LTD • December 19th, 2018 • Pharmaceutical preparations

• Company
  IMMUTEP LTD
• Filed
  December 19th, 2018
• Industry
  Pharmaceutical preparations

THIS AMERICAN DEPOSITARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the three year anniversary of the effective date of a registration statement covering the resale of all of the Warrant Shares underlying the ADSs issuable upon exercise of this Warrant (the “Termination Date”; provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day), but not thereafter, to subscribe for and purchase from Immutep Limited, an Australian public company incorporated under the laws of the Commonwealth of Australia (the “Company”), up to ______ American Depositary Shares (“ADSs”), each ADS representing 100 ordinary shares, no par value, of t

AMERICAN DEPOSITARY SHARES PURCHASE WARRANT PRIMA BIOMED LTD

Prima BioMed LTD • June 29th, 2017 • Pharmaceutical preparations

• Company
  Prima BioMed LTD
• Filed
  June 29th, 2017
• Industry
  Pharmaceutical preparations

THIS AMERICAN DEPOSITARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the 5.5 year anniversary of the Initial Exercise Date (the “Termination Date”; provided, however that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Prima BioMed Ltd ACN 009 237 889, an Australian public company incorporated under the laws of the Commonwealth of Australia (the “Company”), up to [ American Depositary Shares “ADSs”), each ADS representing 100 ordinary shares, no par value, of the Company (the “Ordinary Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one ADS under th